We are delighted to announce positive funding decision by the Estonian Research Council on our 5-year research project "Precision targeting of infiltrative glioblastoma". The project proposes studies on identification and preclinical validation of homing peptides able to penetrate the blood brain barrier and to target infiltrative glioblastoma cells. The project is expected to lead to identification and mechanistic characterization of the infiltrative glioblastoma targeting peptides and execution of the preclinical studies with peptide-guided therapeutic nanoparticles and radiotracers. These studies may lead to a new paradigm of peptide-based precision management of infiltrative glioblastoma.
